ReVIDA® Recovery has released a new educational article, How Much Does Sublocade Cost?, to help individuals and families better understand the financial side of treatment for opioid use disorder (OUD). The post breaks down what determines the cost of Sublocade, which insurance plans cover it, and what options are available to make recovery more affordable.
Sublocade is a once-monthly injection used in medication-assisted treatment (MAT). The medication contains buprenorphine, which attaches to opioid receptors in the brain to reduce cravings and withdrawal symptoms. Because it is a long-acting injection, it offers consistent relief without the ups and downs of daily dosing. For many, this stability allows them to focus on counseling, rebuilding relationships, and regaining a sense of normalcy.
“The goal of Sublocade is to provide consistent relief from withdrawal and cravings,” the article explains. “It gives patients the freedom to focus on therapy and daily life instead of struggling through the physical symptoms of recovery.”
The cost of Sublocade depends on several factors, including insurance coverage, the treatment provider, and the specifics of a person’s recovery plan. ReVIDA® Recovery’s new article breaks down these variables and highlights available financial assistance programs in both Tennessee and Virginia.
For people covered by Medicaid, Sublocade is typically affordable, averaging about $3 per month. Some individuals pay as little as $1, depending on their plan. Both TennCare (Tennessee’s Medicaid program) and Cardinal Care (Virginia’s Medicaid program) include Sublocade as a covered medication for treating opioid use disorder. Those enrolled in Medicare pay an average of $97 out of pocket, and some may qualify for supplemental coverage that lowers this amount even further.
For individuals with commercial insurance, coverage varies by provider. Most major insurers, including Aetna, Anthem Blue Cross Blue Shield, UnitedHealthcare, Humana, Molina Healthcare, and Cigna Healthcare Evernorth, cover Sublocade as part of their MAT benefits. ReVIDA® Recovery accepts many of these plans and works directly with patients to verify benefits before starting treatment.
For those without insurance, the INSUPPORT® Copay Assistance Program can dramatically reduce costs. The program may cover the first two doses and provide lower copays afterward. According to the Sublocade manufacturer, 95% of people enrolled in this program pay little or nothing out of pocket.
“Access to treatment should never depend on a person’s financial situation,” the article emphasizes. “At ReVIDA®, we explore every possible avenue—insurance, scholarships, copay assistance, and payment plans—so that cost is never a reason to delay care.”
In 2025, ReVIDA® Recovery launched its Care for All program, which expanded scholarship opportunities for individuals in Tennessee and Virginia who could not afford treatment otherwise. Each patient is also paired with a care coordinator who assists with more than just finances. Coordinators help with housing applications, court paperwork, job searches, and other practical needs that support long-term recovery.
The article also reinforces that medication alone is not a cure for addiction. The most effective recovery plans combine medication with therapy and case management. ReVIDA® Recovery provides a full range of outpatient services, including individual counseling, group therapy, and family sessions, to help patients develop coping skills and rebuild supportive relationships.
“Recovery is not just about medication,” the article notes. “It’s about learning how to manage stress, rebuild trust, and rediscover purpose. Sublocade helps create the stability people need to make that work possible.”
ReVIDA® Recovery operates multiple outpatient MAT centers throughout Tennessee and Virginia, offering same-day appointments and flexible scheduling for people balancing work, family, or school. The organization’s mission is to make evidence-based, compassionate care available in local communities where it’s needed most.
By publishing this article, ReVIDA® Recovery continues its commitment to education, accessibility, and reducing the stigma surrounding medication-assisted treatment. For many families across Appalachia, clear information like this can be the first step toward understanding what recovery really looks like and how achievable it can be.
To learn more about Sublocade treatment or to explore financial assistance options, call 423-631-0432.
###
For more information about ReVIDA® Recovery Center Oak Ridge, contact the company here:
ReVIDA® Recovery Center Oak Ridge
Meg Paisley
(865) 276-6212
generalinfo@revidarecovery.com
106 Administration Rd #3
Oak Ridge, TN 37830
